National Institute on Aging

FLC Region

Security Lab



Building 31, Room 5C27
31 Center Drive, MSC 2292
Bethesda, MD 20892
United States

Laboratory Representative


NIA, one of the 27 Institutes and Centers of NIH, leads a broad scientific effort to understand the nature of aging and to extend the healthy, active years of life. In 1974, Congress granted authority to form NIA to provide leadership in aging research, training, health information dissemination, and other programs relevant to aging and older people. Subsequent amendments to this legislation designated the NIA as the primary Federal agency on Alzheimer's disease research.

NIA sponsors research on aging through extramural and intramural programs. The extramural program funds research and training at universities, hospitals, medical centers, and other public and private organizations nationwide. The intramural program conducts basic and clinical research in Baltimore, Md. and on the NIH campus in Bethesda, Md.


NIA's mission is to improve the health and well-being of older Americans through research, and specifically, to:
  • Support and conduct high-quality research on aging processes, age related diseases, and special problems and needs of the aged
  • Train and develop highly skilled research scientists from all population groups
  • Develop and maintain state-of-the-art resources to accelerate research progress
  • Disseminate information and communicate with the public and interested groups on health and research advances and on new directions for research

Technology Disciplines

Displaying 1 - 10 of 14
Coacervate Microparticles Useful for the Sustained Release Administration of Therapeutic Agents
Fenoterol and Fenoterol Analogues for Treatment of Glioma, Glioblastoma, and Astrocytoma
Fenoterol and Fenoterol Analogues for Treatment of Glioma, Glioblastoma, and Astrocytoma
Hexanucleotide Repeat in the C9orf72 Gene for the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Human Soluble Receptor for Advanced Glycation End Products (sRAGE) for Treating Vascular Disease, Injury, or Inflammation
Lenalidomide Analogs for the Treatment of Neurodegenerative Disorders and Cancer
Novel Analogues of the Asthma Drug Fenoterol as Liver and Brain Cancer Therapeutic Agents
Novel Inhibitors of Thymic Stromal Lymphopoietin (TSLP) for Cancer Therapy
Novel Tumor-associated Antigen for Cancer Diagnostics and Therapeutics
Preparation of (R,R)-Fenoterol and (R,R)-or (R,S)-Fenoterol Analogues and Their Use in Treating Congestive Heart Failure


Displaying 1 - 3 of 3
NIA Aging Cell Repository
NIA Core Facilities: • Clinical Core Lab • Confocal Microscopy • Gene Expression & Genomics • Flow Cytometry • Bioinformatics • MRI Facility • Proteomics
Nonhuman Primate Tissue Bank Handbook

No Equipment


No Programs


No Funds


No Publications


No News


No Successes


No Licenses